Cardinal Health, Inc. $CAH Shares Purchased by Vanguard Personalized Indexing Management LLC

Vanguard Personalized Indexing Management LLC boosted its position in Cardinal Health, Inc. (NYSE:CAH) by 5.8% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 46,878 shares of the company’s stock after purchasing an additional 2,560 shares during the quarter. Vanguard Personalized Indexing Management LLC’s holdings in Cardinal Health were worth $9,633,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. Aventura Private Wealth LLC acquired a new position in Cardinal Health in the 4th quarter valued at $25,000. Bank of Jackson Hole Trust acquired a new position in Cardinal Health in the 4th quarter valued at $27,000. Jones Financial Companies Lllp raised its stake in Cardinal Health by 198.3% in the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after purchasing an additional 14,034 shares during the last quarter. Palladiem LLC acquired a new position in Cardinal Health in the 4th quarter valued at $28,000. Finally, JPL Wealth Management LLC acquired a new position in Cardinal Health in the 3rd quarter valued at $31,000. 87.17% of the stock is owned by institutional investors and hedge funds.

Cardinal Health Trading Up 1.2%

Shares of NYSE:CAH opened at $226.52 on Tuesday. The business has a 50-day moving average price of $203.46 and a 200 day moving average price of $208.92. The company has a market capitalization of $53.05 billion, a price-to-earnings ratio of 34.64, a PEG ratio of 1.22 and a beta of 0.52. Cardinal Health, Inc. has a 12-month low of $137.75 and a 12-month high of $233.60.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings data on Thursday, April 30th. The company reported $3.17 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.79 by $0.38. The firm had revenue of $60.94 billion during the quarter, compared to the consensus estimate of $62.10 billion. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The company’s quarterly revenue was up 11.0% on a year-over-year basis. During the same period last year, the company earned $2.35 EPS. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. As a group, equities research analysts predict that Cardinal Health, Inc. will post 10.76 earnings per share for the current fiscal year.

Cardinal Health Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st will be given a dividend of $0.5158 per share. This represents a $2.06 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date of this dividend is Wednesday, July 1st. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.51. Cardinal Health’s dividend payout ratio is 31.19%.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on CAH shares. Wall Street Zen downgraded Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Monday. Evercore cut their target price on Cardinal Health from $260.00 to $240.00 and set an “outperform” rating for the company in a research note on Wednesday, April 8th. William Blair began coverage on Cardinal Health in a research note on Tuesday, April 28th. They issued an “outperform” rating for the company. Citigroup cut their target price on Cardinal Health from $249.00 to $245.00 and set a “buy” rating for the company in a research note on Friday, May 1st. Finally, Wells Fargo & Company cut their target price on Cardinal Health from $256.00 to $245.00 and set an “overweight” rating for the company in a research note on Friday, May 1st. One research analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, Cardinal Health currently has an average rating of “Moderate Buy” and an average price target of $246.93.

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.